Table 1 Association of CHI3L1 mRNA expression in human glioma tissues with different clinicopathological features
From: High CHI3L1 expression is associated with glioma patient survival
Variable | Number of cases | CHI3L1 mRNA level | p-value | ||
|---|---|---|---|---|---|
Low n (%) | Medium n (%) | High n (%) | |||
Overall | 98 | 24 (24.5) | 50 (51) | 24 (24.5) | |
Age (Years) | <0.001 | ||||
≤50 | 53 | 23 (43.4) | 24 (45.3) | 6 (11.3) | |
>50 | 45 | 1 (2.2) | 26 (57.8) | 18 (40.0) | |
Gender | 0.683 | ||||
Male | 43 | 12 (27.9) | 22 (51.2) | 9 (20.9) | |
Female | 55 | 12 (21.8) | 28 (50.9) | 15 (27.3) | |
Pathological grade (WHO) | <0.001 | ||||
Grade I | 10 | 0 (0) | 8 (80) | 2 (20) | |
Grade II | 30 | 16 (53.3) | 13 (43.3) | 1 (3.4) | |
Grade III | 20 | 7 (35.0) | 10 (50.0) | 3 (15.0) | |
Grade IV | 38 | 1 (2.6) | 19 (50.0) | 18 (47.4) | |